According to the recent research report titled ‘Africa Molecular Diagnostics Market Size By Technology, Application, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Africa molecular diagnostics market is projected to showcase appealing growth trends over 2020-2026, amassing USD 839 million by the end of the forecast period.
 

Booming elderly population, increasing innovations & advancements in medical field, along with rising disease burden are the key factors stimulating Africa molecular diagnostics market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3001268/
 

Notably, the environment, which is a primary health determinant of community and an individual, is the prominent cause of increasing disease cases in the region. Africa has faced issues relating to access to safe drinking water, improper sanitation, and poor infrastructure. All these factors boost the demand for novel molecular diagnostics for improved health index.
 

With respect to application scope, Africa molecular diagnostics industry from genetic testing segment amassed USD 23 million in 2019, creditable to technological advancements. Genetic testing has advanced from a specialized area for rare conditions to a broad variety of applications for complex diseases and personal use. Various implementation areas such as pre-symptomatic and predictive testing, newborn screening, and pharmacogenetics testing, among others are adding to the segmental expansion.
 

Based on technology type, PCR segment of Africa molecular diagnostics market is projected to expand at 12.5% CAGR through 2026, owing to its usage in rapid recognition of pathogens. Real-Time PCR (RT-PCR) has advanced as an emerging technology that is used in research laboratories and clinical diagnostics as it is regarded as an accurate and fast method for the generation of quantitative and qualitative results.
 

Further, PCR technology will observe high demand with inclination towards less time-consuming molecular testing modalities, thereby preventing contamination during the process. Also, the outbreak of COVID-19 pandemic has stimulated the adoption of RT-PCR tests.
 

Coming to the restraints, lack of skilled professionals, along with hefty cost of disease diagnostics, and limited accessibility are likely to impede Africa molecular diagnostics industry expansion over the coming years.
 

On the regional front, Nigeria molecular diagnostics industry accrued USD 23 million in 2019, owing to growing non-government and government initiatives to spread awareness about tuberculosis, HIV, and other infectious ailments among the population for better patient care. Citing an instance, APIN (AIDS Prevention Initiative in Nigeria) is a non-governmental donor-funded association, formed to treat, care, and prevent infectious diseases like HIV and STDs.
 

Major firms swaying Africa molecular diagnostics market dynamics are Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, Qiagen, Myriad Genetics Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Danaher Corporation, Cleaver Scientific Ltd., Bio-Rad Laboratories Inc., and Becton, Dickinson and Company (BD) among others.